Administrative Core
行政核心
基本信息
- 批准号:10518244
- 负责人:
- 金额:$ 11.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAdvocateAreaBasic ScienceBioinformaticsBiometryCancer BiologyCancer CenterCollaborationsCommunicationCommunitiesDataDevelopmentEnvironmentFacultyFosteringFunding AgencyFutureGoalsGrantHuman ResourcesImmuneInformation DisseminationInfrastructureInterventionJointsLaboratoriesLeadLeadershipLinkMalignant NeoplasmsMalignant neoplasm of pancreasMedical centerMetabolicMetabolismMonitorNational Cancer InstituteNebraskaOccupational activity of managing financesOrganoidsPilot ProjectsProgress ReportsRecordsResearchResearch PersonnelResearch Project GrantsResistanceResourcesScheduleScienceScientistSignal TransductionStromal NeoplasmStudentsTalentsTechnical ExpertiseTestingTissuesTranslational ResearchTravelUniversitiesWorkanticancer researchcancer educationcancer therapydata managementgraduate studentinnovationinterestmeetingsmembermouse modelneoplasm resourcenext generationnovelnovel therapeutic interventionoperationpreventprogramsprospectiveresistance mechanismtherapy resistanttranslational cancer researchtranslational pipelinetranslational research programtumortumor metabolismweb portal
项目摘要
ADMINISTRATIVE CORE
Abstract
The administrative core will lead, manage, and support all activities of the Acquired Resistance to Therapy
Network (ARTNet) Center for Pancreatic Cancer (ACPC). It will represent ACPC at the trans-ARTNet network
activities, and in interactions with NCI. The ARTNet administrative core will be responsible for managing the
activities of the synergistic research ACPC projects with scientific and technical expertise and resources in the
areas of therapy resistance, signaling, metabolism, pancreatic cancer biology, organoid and mouse models,
immune and non-immune stroma, and PDAC tissues for studying the acquired therapy resistance in cancer. The
core leadership will provide expertise spanning the basic to translational spectrum, consistent with the
overarching theme of ACPC, with track records of building and guiding large scientific teams to successfully
advance fields in transformative ways. We will utilize strategic management with innovative approaches,
including an educational component to bring new talent into the field, engage diverse teams to facilitate new
ideas, leverage national talent pertinent to the proposed goals, engage university leadership in building support
for cutting-edge science, and utilize dedicated university expertise to facilitate engagement with basic and
translational research programs to grow ARTNet centric interests. The administrative core will provide support
for personnel involved in the administration, coordination, communication, biostatistics, and bioinformatics to
support the ARTNet activities within the center and campus, other ARTNet centers, ARTNet Coordinating Data
and Management Center (CDMC) and National Cancer Institutes (NCI). The administrative core will also provide
scientific oversight, result dissemination, budgetary oversight, and clerical functions associated with the overall
research program in this ACPC application. The core will implement center-wide activities which include,
developing new collaborations on the ACPC projects, organize annual retreat, support acquired cancer therapy
resistance seminar speakers within various academic units, advocate for the next generation of scientists
(graduate students, postdoctoral researchers, and junior faculty) in the ACPC member laboratories. Finally, the
administrative core will represent ACPC on the ARTNet steering committee.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pankaj Kumar Singh其他文献
Utilization of wastewater as nutrient media and biomass valorization in marine Chrysophytes- Chaetoceros and Isochrysis
废水作为营养介质的利用和海洋金藻植物-角毛藻和等鞭金藻的生物量增值
- DOI:
10.1016/j.ecmx.2020.100062 - 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Pankaj Kumar Singh;Raya Bhattacharjya;A. Saxena;Bharti Mishra;A. Tiwari - 通讯作者:
A. Tiwari
In silico guided development of imine-based inhibitors for resistance-deriving kinases
计算机引导开发基于亚胺的耐药激酶抑制剂
- DOI:
10.1080/07391102.2018.1491893 - 发表时间:
2018 - 期刊:
- 影响因子:4.4
- 作者:
Pankaj Kumar Singh;O. Silakari - 通讯作者:
O. Silakari
MO23-3 Primary bony tumors of cranio-cervical junction and upper cervical spine: Management and their outcome from 21 cases
- DOI:
10.1016/j.annonc.2023.09.214 - 发表时间:
2023-11-01 - 期刊:
- 影响因子:
- 作者:
Sivaraman Kumarasamy;Pankaj Kumar Singh;Deepak Agrawal;Rajinder Kumar;P Sarat Chandra;Shashank Sharad Kale - 通讯作者:
Shashank Sharad Kale
Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: Synthesis, <em>in-vivo</em>, <em>in-vitro</em> and <em>in-silico</em> analysis
- DOI:
10.1016/j.bioorg.2021.105068 - 发表时间:
2021-09-01 - 期刊:
- 影响因子:
- 作者:
Devendra Kumar;Ravi Ranjan Kumar;Shelly Pathania;Pankaj Kumar Singh;Sourav Kalra;Bhupinder Kumar - 通讯作者:
Bhupinder Kumar
Amphotericin B loaded nanoemulsion: Optimization, characterization and <em>in-vitro</em> activity against <em>L. donovani</em> promastigotes
- DOI:
10.1016/j.parint.2023.102848 - 发表时间:
2024-06-01 - 期刊:
- 影响因子:
- 作者:
Vikram Mohanlal Prajapat;Mayur Aalhate;Anitha Sriram;Srushti Mahajan;Indrani Maji;Ujala Gupta;Diksha Kumari;Kuljit Singh;Nitin Pal Kalia;Kamal Dua;Sachin Kumar Singh;Pankaj Kumar Singh - 通讯作者:
Pankaj Kumar Singh
Pankaj Kumar Singh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pankaj Kumar Singh', 18)}}的其他基金
Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
FOLFIRINOX 在胰腺癌中获得性耐药的代谢调节
- 批准号:
10518247 - 财政年份:2022
- 资助金额:
$ 11.83万 - 项目类别:
Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
FOLFIRINOX 在胰腺癌中获得性耐药的代谢调节
- 批准号:
10707541 - 财政年份:2022
- 资助金额:
$ 11.83万 - 项目类别:
Mitochondrial calcium signaling in pancreatic cancer metastasis and progression
胰腺癌转移和进展中的线粒体钙信号传导
- 批准号:
10363987 - 财政年份:2022
- 资助金额:
$ 11.83万 - 项目类别:
Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer
ME2 介导的胰腺癌肿瘤抑制的分子基础
- 批准号:
10671029 - 财政年份:2022
- 资助金额:
$ 11.83万 - 项目类别:
Mitochondrial calcium signaling in pancreatic cancer metastasis and progression
胰腺癌转移和进展中的线粒体钙信号传导
- 批准号:
10565949 - 财政年份:2022
- 资助金额:
$ 11.83万 - 项目类别:
相似海外基金
Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas
通过合作进行治愈:利用合作团体对抗慢性淋巴细胞白血病和 B 细胞淋巴瘤
- 批准号:
10566833 - 财政年份:2023
- 资助金额:
$ 11.83万 - 项目类别:
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709602 - 财政年份:2022
- 资助金额:
$ 11.83万 - 项目类别: